2-[4-(3'-FLUOROBENZYLOXY)-3-TRIFLUOROMETHOXYPHENYL]-OXAZOLINE-4-HYDROXAMIC-ACID
Compound with spectra: 1 NMR
![2-[4-(3'-FLUOROBENZYLOXY)-3-TRIFLUOROMETHOXYPHENYL]-OXAZOLINE-4-HYDROXAMIC-ACID](/api/compound/H71MtnnD6W4.png?ph=true&h=300&w=458 "2-[4-(3'-FLUOROBENZYLOXY)-3-TRIFLUOROMETHOXYPHENYL]-OXAZOLINE-4-HYDROXAMIC-ACID")
| SpectraBase Compound ID | H71MtnnD6W4 |
|---|---|
| InChI | InChI=1S/C18H14F4N2O5/c19-12-3-1-2-10(6-12)8-27-14-5-4-11(7-15(14)29-18(20,21)22)17-23-13(9-28-17)16(25)24-26/h1-7,13,26H,8-9H2,(H,24,25)/t13-/m1/s1 |
| InChIKey | DVTVNUUHLRZTGI-CYBMUJFWSA-N |
| Mol Weight | 414.31 g/mol |
| Molecular Formula | C18H14F4N2O5 |
| Exact Mass | 414.083884 g/mol |
| Enantiomer InChIKey | DVTVNUUHLRZTGI-ZDUSSCGKSA-N |
| Racemate InChIKey | DVTVNUUHLRZTGI-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(4E)-2-(1,3-Benzodioxol-5-yl)-4-(4-fluorobenzylidene)-1,3-oxazol-5(4H)-one
Oxazol-5(4H)-one, 2-(3,4-methylenedioxyphenyl)-4-(4-nitrobenzylideno)-
(4Z)-4-(3-methoxy-4-{[3-(trifluoromethyl)benzyl]oxy}benzylidene)-2-phenyl-1,3-oxazol-5(4H)-one
5(4H)-oxazolone, 2-(1,3-benzodioxol-5-yl)-4-[[4-(dimethylamino)phenyl]methylene]-, (4Z)-
5(4H)-oxazolone, 2-(1,3-benzodioxol-5-yl)-4-[(4-methoxyphenyl)methylene]-, (4Z)-
5(4H)-oxazolone, 2-(1,3-benzodioxol-5-yl)-4-[(4-methylphenyl)methylene]-, (4Z)-
(4Z)-2-(1,3-benzodioxol-5-yl)-4-(4-bromobenzylidene)-1,3-oxazol-5(4H)-one
N-(4-{(4Z)-4-[4-(benzyloxy)-3-methoxybenzylidene]-5-oxo-4,5-dihydro-1,3-oxazol-2-yl}phenyl)acetamide
4-[N-(1,2,-diphenylethyl)formimidoyl]-2-methoxyphenol, 3,4,5-trimethoxybenzoate
(4Z)-4-{4-[(2-chlorobenzyl)oxy]-3-methoxybenzylidene}-2-(4-fluorophenyl)-1,3-oxazol-5(4H)-one
| Title | Journal or Book | Year |
|---|---|---|
| Potent, Novel in Vitro Inhibitors of thePseudomonasaeruginosaDeacetylase LpxC | Journal of Medicinal Chemistry | 2002 |